White Guide and Orange Guide Formatting Project - Pfizer

Discussing Pfizer Products While Meeting about Quality Programs
Orange Guide – Chapter 14: CGC Tools and Resources
Q. If I am meeting with a customer to discuss a Quality Program, am I prohibited
from discussing Pfizer products during that meeting?
A. You are permitted to discuss Pfizer products during the meeting only if you
ensure that the customer understands that Pfizer does not expect or intend
that the customer use our products as a condition of Pfizer providing the
program. The program must be provided with no strings attached. Similarly,
you cannot use data obtained from the customer program (e.g., the number of
patients participating in the program reaching goal) to support the use of Pfizer
products. Your discussions about Pfizer products should be clearly separate
from your discussions about the Quality Program.
The decision to provide a Quality Program should be based only on the customer’s capabilities (as
determined by Pfizer), not because providing the program will improve your relationship with the
customer or subsidize costs the customer would otherwise have had to pay. Even though an improved
customer relationship might be an unintended result of the Quality Program, you should never offer or
provide such a program with that intent.
Pfizer’s reason to offer or provide a Quality Program must never be to:
Establish or improve Pfizer’s relationship with that HCP or institution;
Gain or improve access to an HCP or institution;
Reward past prescribing or induce future prescribing;
Influence an upcoming formulary decision; or
Offer an implied discount on the price of our products.
225
Rev. 09/12
Page 6 of 7